QQQ
+ 0.00
387.12
+ 0%
BTC/USD
-667.94
56516.13
-1.17%
DIA
+ 0.00
340.46
+ 0%
SPY
+ 0.04
450.46
+ 0.01%
TLT
+ 0.00
152.34
+ 0%
GLD
+ 0.05
166.11
+ 0.03%

Expert Ratings For Amgen

October 12, 2021 12:31 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Expert Ratings For Amgen

Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 1 4 0 0
Last 30D 0 0 1 0 0
1M Ago 0 0 1 0 0
2M Ago 0 0 1 0 0
3M Ago 0 1 1 0 0

In the last 3 months, 5 analysts have offered 12-month price targets for Amgen. The company has an average price target of $244.0 with a high of $280.00 and a low of $220.00.

Below is a summary of how these 5 analysts rated Amgen over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the move negative analysts are on the stock

price target chart

This current average represents a 6.78% increase from the previous average price target of $261.75.

What Are Analyst Ratings?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Analyst Ratings

Related Articles

Analyst Ratings For Amgen

Analyst Ratings For Amgen

Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following analyst ratings: read more
Where Amgen Stands With Analysts

Where Amgen Stands With Analysts

Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following analyst ratings: read more

Where Amgen Stands With Analysts

Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago read more

Expert Ratings for Amgen

Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago read more